AZBio Trailblazers Conversations Focus on Investing in Arizona

Making LIFE Better by Investing in Arizona was the theme of the 2015 AZBio Trailblazer Awards and legislative luncheon.  

AZBio president and CEO, Joan Koerber-Walker, kicked things off with two big announcements directly relating to two opportunities designed to positively impact the landscape for life science investment in Arizona.

Each year, AZBio shares with the community the key factors that lead to growth in this vital economic sector.  The 2015 Trailblazer honorees are  selected from Arizona’s State Legislature based on their engagement with the bioscience community as well as committee and voting records on key issues that shape the key bioscience growth factors.

The Arizona BioIndustry Association (AZBio) honored 10 Arizona Legislators on December 10, 2015 for their service to the community and for championing research, education, innovation, the growth of Arizona’s bioscience sector and ensuring that Arizona patients benefit from life science innovation.  The honorees were recognized by the leaders of Arizona’s bioscience and healthcare community at the 2015 AZBio Trailblazer Awards during a special appreciation luncheon for members, elected officials and legislators.


  • Senator  Nancy Barto
  • Senator Jeff Dial
  • Senator Steve Pierce
  • Senator Kimberly Yee
  • Senator Bob Worsley
  • Speaker Pro Tem Bob Robson
  • Representative Heather Carter
  • Representative Karen Fann
  • Representative Eric Meyer, MD
  • Representative T.J. Shope

Click Here for the Full Photo Set provided by Mark Goldstein of the International Research Center.
Making LIFE Better requires investment. Ulthera CEO Matt Likens, Life Science Investor JP Millon and ASU Biodesign’s Dr. Ray DuBois share insights on Arizona’s Life Science Investment Landscape with Joan Koerber-Walker CEO of AZBio at Trailblazers 2015.

Making LIFE Better by Investing In Arizona featuring  Raymond N. DuBois, MD,PhD of the Biodesign Institute at Arizona State University, life science investor and industry executive Jean-Pierre Million, and Matthew E. Likens, President and Chief Executive Officer of the Ulthera Division of Merz, Inc.

Posted in AZBio News.